3 Year Absolute Returns
31.49% ↑
NAV (₹) on 21 Oct 2026
27.96
1 Day NAV Change
-0.01%
Risk Level
Very High Risk
Rating
-
DSP Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by DSP Investment Managers Pvt. Ltd.. Launched on 12 Nov 2018, investors can start with a lumpsum investment ... Read more
AUM
₹ 3,750.04 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 66.30% |
| Hospitals & Medical Services | 16.49% |
| Foreign Securities | 8.21% |
| Treps/Reverse Repo | 6.81% |
| International Mutual Fund Units | 1.10% |
| Finance - Non Life Insurance | 1.02% |
| Medical Equipment & Accessories | 0.14% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| IPCA Laboratories Limited | 8.13% | ₹ 305.01 | Pharmaceuticals |
| Sun Pharmaceutical Industries Limited | 7.44% | ₹ 278.96 | Pharmaceuticals |
| Cipla Limited | 7.18% | ₹ 269.39 | Pharmaceuticals |
| TREPS / Reverse Repo Investments | 6.81% | ₹ 255.23 | Others |
| Sai Life Sciences Limited | 6.52% | ₹ 244.33 | Pharmaceuticals |
| Gland Pharma Limited | 6.15% | ₹ 230.58 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 6.07% | ₹ 227.60 | Hospitals & Medical Services |
| Globus Medical Inc | 5.15% | ₹ 193.24 | Others |
| Alkem Laboratories Limited | 4.75% | ₹ 177.96 | Pharmaceuticals |
| Divi's Laboratories Limited | 4.17% | ₹ 156.30 | Pharmaceuticals |
| Cohance Lifesciences Limited | 3.79% | ₹ 142.21 | Pharmaceuticals |
| Alembic Pharmaceuticals Limited | 3.18% | ₹ 119.07 | Pharmaceuticals |
| Kovai Medical Center And Hospital Limited | 2.83% | ₹ 106.21 | Hospitals & Medical Services |
| Pfizer Limited | 2.72% | ₹ 102.16 | Pharmaceuticals |
| Concord Biotech Limited | 2.70% | ₹ 101.07 | Pharmaceuticals |
| Procter & Gamble Health Limited | 2.36% | ₹ 88.61 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 2.36% | ₹ 88.52 | Hospitals & Medical Services |
| Indoco Remedies Limited | 2.26% | ₹ 84.93 | Pharmaceuticals |
| Intuitive Surgical Inc | 1.95% | ₹ 73.25 | Others |
| Thyrocare Technologies Limited | 1.91% | ₹ 71.64 | Hospitals & Medical Services |
| Manipal Health Enterprises Limited | 1.85% | ₹ 69.42 | Hospitals & Medical Services |
| Unichem Laboratories Limited | 1.64% | ₹ 61.57 | Pharmaceuticals |
| Syngene International Limited | 1.35% | ₹ 50.60 | Pharmaceuticals |
| Nephrocare Health Services Limited | 1.12% | ₹ 41.89 | Hospitals & Medical Services |
| Global X Funds - Global X Genomics & Biotechnology ETF | 1.10% | ₹ 41.44 | Others |
| ICICI Lombard General Insurance Co Limited | 1.02% | ₹ 38.38 | Finance - Non Life Insurance |
| Aarti Drugs Limited | 0.98% | ₹ 36.72 | Pharmaceuticals |
| Abbott Laboratories | 0.80% | ₹ 29.98 | Others |
| Eris Lifesciences Limited | 0.72% | ₹ 26.92 | Pharmaceuticals |
| Jupiter Life Line Hospitals Limited | 0.35% | ₹ 13.10 | Hospitals & Medical Services |
| Grail Inc | 0.31% | ₹ 11.75 | Others |
| Abbott India Limited | 0.26% | ₹ 9.92 | Pharmaceuticals |
| Laxmi Dental Limited | 0.14% | ₹ 5.37 | Medical Equipment & Accessories |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 6.57% | 1.59% | -4.62% | 9.56% |
| Category returns | 1.88% | -1.84% | 2.14% | 17.66% |
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹33.24 | 90.88% | 281.41% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹33.24 | 90.88% | 281.41% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹33.24 | 90.88% | 281.41% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹30.99 | 88.34% | 266.02% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹30.99 | 88.34% | 266.02% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹30.99 | 88.34% | 266.02% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.03 | 14.09% | 137.11% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.03 | 14.09% | 137.11% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.03 | 14.09% | 137.11% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹27.97 | 13.00% | 129.56% | 0.00% | ₹11,493 | 1.79% |
Very High
|
What is the current NAV of DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the fund size (AUM) of DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
What are the historical returns of DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the risk level of DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the minimum investment amount for DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article